Intravacc announces publication of In Vitro alternative to replace animal pyrogen test for vaccines

Contributed by: GlobeNewswire

Tags

Intravacc

More Like This

GlobeNewswire associated0

Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention

Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2

Intravacc Secures French CIR Approval to Support Vaccine R&D Partnerships

Intravacc launches new website with a wealth of scientific knowledge to elevate vaccine innovation

Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections

SpikImm Announces the Signature of an Exclusive License Option and Collaboration Agreement With SATT Conectus for the Development of a Prophylactic Treatment Against the BK Virus, Causing Severe Complications in Transplant Patients

Virometix AG Announces Positive Data from Phase 1 Trial of V-212, a Fully Synthetic, Serotype-Independent Vaccine Development Candidate for the Prevention of Pneumococcal Disease

BioNet’s Recombinant Pertussis Vaccine Submitted to European Medicines Agency (EMA)